BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 31607902)

  • 21. Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair.
    Tiberi M; Chiurchiù V
    Front Cell Neurosci; 2021; 15():673549. PubMed ID: 33981203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel lipid mediator PD1
    Hansen TV; Dalli J; Serhan CN
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():103-110. PubMed ID: 28602942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
    Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
    Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition.
    Al-Shaer AE; Buddenbaum N; Shaikh SR
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jul; 1866(7):158936. PubMed ID: 33794384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolvins and protectins: mediating solutions to inflammation.
    Kohli P; Levy BD
    Br J Pharmacol; 2009 Oct; 158(4):960-71. PubMed ID: 19594757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-resolution therapeutics for cardiovascular diseases.
    Heinz J; Marinello M; Fredman G
    Prostaglandins Other Lipid Mediat; 2017 Sep; 132():12-16. PubMed ID: 28450270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments of specialized pro-resolving mediators in periodontitis.
    Liu YC
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update.
    Trépanier MO; Hopperton KE; Orr SK; Bazinet RP
    Eur J Pharmacol; 2016 Aug; 785():187-206. PubMed ID: 26036964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
    Kotlyarov S; Kotlyarova A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins.
    Barnig C; Lutzweiler G; Giannini M; Lejay A; Charles AL; Meyer A; Geny B
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
    Recchiuti A; Serhan CN
    Front Immunol; 2012; 3():298. PubMed ID: 23093949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell.
    Weylandt KH
    Eur J Pharmacol; 2016 Aug; 785():108-115. PubMed ID: 26546723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
    Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
    BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases.
    Ungaro F; Rubbino F; Danese S; D'Alessio S
    Front Immunol; 2017; 8():1331. PubMed ID: 29109724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
    Nowak JZ
    Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
    Duvall MG; Levy BD
    Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary fish hydrolysate supplementation containing n-3 LC-PUFAs and peptides prevents short-term memory and stress response deficits in aged mice.
    Chataigner M; Mortessagne P; Lucas C; Pallet V; Layé S; Mehaignerie A; Bouvret E; Dinel AL; Joffre C
    Brain Behav Immun; 2021 Jan; 91():716-730. PubMed ID: 32976934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pro-resolving lipid mediators in inflammatory lung diseases].
    Eickmeier O; Hilberath JN; Zielen S; Haworth O
    Pneumologie; 2011 Mar; 65(3):149-58. PubMed ID: 21117020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia.
    Das UN
    Nutrition; 2015 Sep; 31(9):1083-95. PubMed ID: 26233865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.